Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. - Andriulli,A.; Clemente,R.; Solmi,L. (Gastrointest Endosc, 2002)